Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Teriparatide on Femoral Neck Fracture Healing (Second Study)
2011-001116-65Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neck Of Femur Fracture and intertrochanteric fracture comparing Teriparatide with Placebo (2 arms). Primary endpoints: Overall success of femoral neck fracture healing at 24 months and Radiographic evidence of healing. Started Nov 2011; status: completed.
02
Drugs
teriparatide
03
Conditions
Neck Of Femur Fractureintertrochanteric fracture
Beyond the preview
Go deeper on 2011-001116-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001116-65.